Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Savage DG, Szydlo RM, Goldman JM (1997) Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol 96:111–116CrossRefPubMed
2.
Akay OM, Mutlu F, Gülbaş Z (2016) Platelet dysfunction in patients with chronic myeloid leukemia: does imatinib mesylate improve it? Turk J Haematol. 33:127–130CrossRefPubMedPubMedCentral
3.
Ng AP, Servadei P, Tuckfield A, Friedhuber A, Grigg A (2009) Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase. Blood Coagul Fibrinolysis 20:81–83CrossRefPubMed
4.
Abdulhamid MM, Li YM, Hall WA (2011) Spontaneous acute subdural hematoma as the initial manifestation of chronic myeloid leukemia. J Neurooncol 101:513–516CrossRefPubMed
5.
Jain A (2015) A rare case of chronic myeloid leukemia with acquired von Willebrand disease presenting as subdural hematoma. J Cancer Res Ther 11:1022CrossRefPubMed
Metadata
Title
Spontaneous Acute Subdural Hematoma as an Initial Presentation of Chronic Myeloid Leukemia
Authors
Ankur Jain
Pooja Prasad
Sumita Chaudhry
DK Gupta
Sumita Saluja
Publication date
01-07-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01115-8

Other articles of this Issue 3/2019

Indian Journal of Hematology and Blood Transfusion 3/2019 Go to the issue

Correspondence

Mechanical Cryopreservation of Peripheral Blood Stem Cell: Initial Experience from a Tertiary Care Hospital

Short Communication

Dengue Virus NS1 Exposure Affects von Willebrand Factor Profile and Platelet Adhesion Properties of Cultured Vascular Endothelial Cells

Short Communication

Review of the Abstracts on Advances in Transfusion Medicine at Hematocon 2018

Original Article

Effect of Prophylactic Management of Hemophilia on Bleeding Episodes

Original Article

Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia

Correspondence

Detection of BCR/PDGRFα Fusion Using Dual Colour Dual Fusion BCR/ABL1 Probe: An Illustrative Report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits